Miglitol



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 31.9%
Type 2 Diabetes Mellitus 28.5%
Hypertension 13.6%
Constipation 3.8%
Nephrotic Syndrome 3.0%
Angina Pectoris 2.8%
Hypercholesterolaemia 1.8%
Gastritis 1.4%
Rheumatoid Arthritis 1.4%
Type 1 Diabetes Mellitus 1.4%
Arteriosclerosis 1.2%
Blood Pressure Management 1.2%
Gastritis Prophylaxis 1.2%
Pulmonary Tuberculosis 1.2%
Hyperlipidaemia 1.0%
Percutaneous Coronary Intervention 1.0%
Prophylaxis Against Gastrointestinal Ulcer 1.0%
Urethritis 1.0%
Atrial Fibrillation 0.8%
Cerebrovascular Accident Prophylaxis 0.8%
Hepatic Function Abnormal 17.5%
Hypoglycaemia 14.5%
Liver Disorder 13.9%
Pneumatosis Intestinalis 9.0%
Liver Function Test Abnormal 6.0%
Ileus 5.4%
Intestinal Ischaemia 3.6%
Subileus 3.6%
Diarrhoea 3.0%
Hepatitis 3.0%
Transaminases Increased 3.0%
Alanine Aminotransferase Increased 2.4%
Malaise 2.4%
Chest Discomfort 1.8%
Constipation 1.8%
Drug-induced Liver Injury 1.8%
Fall 1.8%
Gastric Cancer 1.8%
Hepatic Enzyme Increased 1.8%
Intestinal Obstruction 1.8%
Secondary
Hypertension 24.7%
Type 2 Diabetes Mellitus 20.7%
Diabetes Mellitus 17.2%
Angina Pectoris 4.7%
Cardiovascular Disorder 4.0%
Hypercholesterolaemia 3.0%
Rash 2.8%
Drug Use For Unknown Indication 2.6%
Lacunar Infarction 2.3%
Gastritis Prophylaxis 2.1%
Product Used For Unknown Indication 2.1%
Gastritis 1.9%
Osteoarthritis 1.9%
Percutaneous Coronary Intervention 1.9%
Cough 1.6%
Cholelithiasis 1.4%
Depression 1.4%
Insomnia 1.4%
Anxiety Disorder 1.2%
Cerebral Infarction 1.2%
Liver Disorder 19.3%
Prostate Cancer 12.0%
Hypoglycaemia 10.8%
Liver Function Test Abnormal 8.4%
Convulsion 4.8%
Hepatic Function Abnormal 4.8%
Colonic Polyp 3.6%
Diarrhoea 3.6%
Drug Exposure During Pregnancy 3.6%
Thrombocytopenia 3.6%
Ventricular Extrasystoles 3.6%
Alanine Aminotransferase Increased 2.4%
Drug-induced Liver Injury 2.4%
In-stent Coronary Artery Restenosis 2.4%
Intentional Overdose 2.4%
Intestinal Obstruction 2.4%
Myocardial Ischaemia 2.4%
Pruritus Generalised 2.4%
Rhabdomyolysis 2.4%
Tumour Marker Increased 2.4%
Concomitant
Diabetes Mellitus 21.4%
Hypertension 20.6%
Type 2 Diabetes Mellitus 9.7%
Product Used For Unknown Indication 6.8%
Prophylaxis 5.9%
Rheumatoid Arthritis 4.9%
Drug Use For Unknown Indication 4.4%
Hepatitis C 3.7%
Hyperlipidaemia 3.2%
Gastritis 2.5%
Cardiac Failure 2.3%
Atrial Fibrillation 2.2%
Osteoporosis 1.9%
Metastatic Renal Cell Carcinoma 1.8%
Constipation 1.8%
Hyperuricaemia 1.8%
Insomnia 1.5%
Renal Transplant 1.4%
Multiple Myeloma 1.2%
Thrombosis Prophylaxis 1.2%
Hypoglycaemia 11.9%
Renal Impairment 9.1%
Liver Disorder 7.7%
Hepatic Function Abnormal 7.0%
White Blood Cell Count Decreased 6.3%
Anaemia 5.6%
Interstitial Lung Disease 5.6%
Platelet Count Decreased 4.9%
Rash 4.9%
Lacunar Infarction 4.2%
Umbilical Cord Around Neck 4.2%
Diabetic Ketoacidosis 3.5%
Gastrointestinal Haemorrhage 3.5%
Nasopharyngitis 3.5%
Prostatic Specific Antigen Increased 3.5%
Renal Failure 3.5%
Angina Pectoris 2.8%
Calculus Urinary 2.8%
Condition Aggravated 2.8%
Decreased Appetite 2.8%
Interacting
Computerised Tomogram 100.0%
Thrombocytopenia 100.0%